Clinical Trial Update: Frontline Asciminib Combination in Chronic Phase CML [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating frontline asciminib in chronic phase chronic myeloid leukemia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: University of Jena | Conditions: Chronic Myeloid Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING